Targacept reports mixed depression drug data
Pharmaceutical Business Review - Nov 10, 2006A phase II trial of mecamylamine hydrochloride as an augmentation treatment for major depression has delivered mixed results, its manufacturer Targacept has ...
Source: www.pharmaceutical-business-review.com
Click here for more information about depression test depression test
<< Home